- References (3)
Publishing research using ab141125? Please let us know so that we can cite the reference in this datasheet.
ab141125 has been referenced in 3 publications.
- García C et al. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPAR? receptor. J Neuroinflammation 15:19 (2018). PubMed: 29338785
- Degrelle SA et al. New Transcriptional Reporters to Quantify and Monitor PPAR?Activity. PPAR Res 2017:6139107 (2017). PubMed: 29225614
- Zhu HY et al. Peroxisome proliferator-activated receptor-? agonist troglitazone suppresses transforming growth factor-ß1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro. Am J Transl Res 8:3460-70 (2016). PubMed: 27648136